JCNN News Summaries - Japan Corporate News Network - Daiichi Products Covered by National Health Insurance
Monday, October 27th, 2008 Tokyo, Apr 5, 2006 - (JCN) - Some of Daiichi Pharmaceutical’s Intrathecal Baclofen therapy products are now listed for national health insurance reimbursement. One of them is the SynchroMed infusion system that comprises of the SynchroMed EL pump and the InDura catheter.
Intrathecal Gabalon (baclofen) and the SynchroMed system are used to treat severe spasticity in patients if conventional treatments don’t. The system i…
